ZEAL& ZEALAND PHARMA

Live / Registered — Registered (as of 22 Sept 2026)

What this means for you

Registered since 22 Sept 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 22 Sept 2032: the §71 affidavit of use).

Record

Serial number
79428653
Registration number
8445602
Mark type
Design + words
Filed
27 May 2025
Published for opposition
04 Aug 2026
Registered
22 Sept 2026
Next maintenance filing
§71 affidavit of use, due by 22 Sept 2032 (grace period to 22 Mar 2033)
Attorney of record
Miriam D. Trudell

Goods and services

  • Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of diseases and disorders in humans, namely, endocrine, nutritional, metabolic, immune, blood, nervous system, sensory organ, musculoskeletal, connective tissue, circulatory, respiratory, digestive, genitourinary, and skin disorders, diabetes, obesity, gastrointestinal diseases and conditions such as Congenital HyperInsulinism (CHI), hypoglycemia, Short Bowel Syndrome (SBS), and chronic inflammation, Inflammatory Bowel Disease (IBD) and Metabolic dysfunction-associated steatohepatitis (MASH); delivery devices containing pharmaceutical products, namely, syringes sold filled with pharmaceutical preparations for the treatment of diseases and disorders in humans, namely, endocrine, nutritional, metabolic, immune, blood, nervous system, sensory organ, musculoskeletal, connective tissue, circulatory, respiratory, digestive, genitourinary, and skin disorders, diabetes, obesity, gastrointestinal diseases and conditions such as Congenital HyperInsulinism (CHI), hypoglycemia, Short Bowel Syndrome (SBS), and chronic inflammation, Inflammatory Bowel Disease (IBD) and Metabolic dysfunction-associated steatohepatitis (MASH); chemical preparations for use in medical devices, namely, chemical preparations for pharmaceutical purposes for the treatment of diseases and disorders in humans, namely, endocrine, nutritional, metabolic, immune, blood, nervous system, sensory organ, musculoskeletal, connective tissue, circulatory, respiratory, digestive, genitourinary, and skin disorders, diabetes, obesity, gastrointestinal diseases and conditions such as Congenital HyperInsulinism (CHI), hypoglycemia, Short Bowel Syndrome (SBS), and chronic inflammation, Inflammatory Bowel Disease (IBD) and Metabolic dysfunction-associated steatohepatitis (MASH)
  • Class 009 — Scientific and electric apparatus: Downloadable electronic publications, namely, leaflets, books, booklets, handouts, magazines as well as medical, instructional and teaching material, all in the field of diabetes, obesity, and gastrointestinal diseases; downloadable software applications for use with mobile devices for monitoring and the management of diseases and illnesses in human beings; computer hardware and downloadable software, for use with medical injection devices for collecting, transmitting, and displaying medical data; downloadable medical software for the management of diseases and illnesses in human beings; downloadable software intended for medical purposes that perform these purposes without being part of a medical device, namely, for monitoring and managing diseases in humans
  • Class 010 — Medical apparatus: Medical apparatus and instruments being syringes, insulin pumps, adhesive medical pads; medical apparatus and instruments for reconstitution and injection of pharmaceutical preparations; medical apparatus and instruments, namely, injection devices for administration of pharmaceutical preparations, medical infusion pumps, infusion pump controllers, adhesive infusion devices for administering drugs; digitally connected medical devices for monitoring the dispensation of pharmaceutical preparations for use in connection with the management of diseases and illnesses in the human body; medical and surgical apparatus and instruments, namely, injection devices for the administration of pharmaceutical preparations and the wireless transmission of medical data in connection with the management of diseases and illnesses in the human body; medical devices, namely, automatic needle insertion devices, protection caps for syringes and medical pens; hypodermic needles for injections; cartridges and carpules, sold empty, for administration pharmaceutical preparations
  • Class 042 — Scientific and technological services: Scientific and technological services and research and design relating thereto, namely, scientific research and development in the field of medicine, pharmaceuticals, genetics, biology and biotechnology; providing scientific research information on diseases and illnesses in the human body; providing websites and hosting of mobile apps featuring technology that enable users to record, track, and generate reports regarding the condition, treatment and the management of diseases and illnesses in the human body; computer services, namely, providing a website featuring technology enabling users to access data concerning medical analysis and management of diseases and illnesses in the human body; scientific industrial analysis and research services in the field of medicine, pharmaceuticals, genetics, biology and biotechnology; medical, biological, biotechnological, genetic, medical laboratory research and pharmaceutical research, pharmaceutical design and development services; medical laboratory research in the field of medicine, pharmaceuticals, genetics, biology and biotechnology; information and consultancy services relating to all the aforesaid
  • Class 044 — Medical, beauty and agricultural services: Providing medical services via websites and mobile apps for the management of diseases and illnesses in the human body; providing medical information and medical counselling relating to the management of diseases and illnesses in the human body.

Owner

Prosecution history

  • 22 Sept 2026 — REGISTERED-PRINCIPAL REGISTER
  • 07 Aug 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
  • 07 Aug 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
  • 07 Aug 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
  • 04 Aug 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 04 Aug 2026 — PUBLISHED FOR OPPOSITION
  • 29 Jul 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 06 Jul 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 03 Jul 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
  • 03 Jul 2026 — EXAMINER'S AMENDMENT ENTERED
  • 03 Jul 2026 — EXAMINERS AMENDMENT E-MAILED
  • 03 Jul 2026 — EXAMINERS AMENDMENT -WRITTEN
  • 12 Jun 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 12 Jun 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 12 Jun 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED

View this trademark record on Rightsy